drugset / Trial / NCT03953820

Diazepam Buccal Film (DBF) - Diastat Rectal Gel (DRG) Crossover Study

NCT03953820

Phase 1/2 Completed 31 enrolled Aquestive Therapeutics
RandomizedCrossoverOpen-labelTreatment

Summary

This was a multiple centers, single-dose, open-label, randomized two-sequence crossover, two-period study to evaluate the pharmacokinetics (PK) of single doses of Diazepam Buccal Film (DBF) compared with Diastat® Rectal Gel (DRG) under fed conditions in adult male and female participants on a stable concomitant regimen of anti-epileptic drugs for the treatment of epilepsy.

Timeline

Start
2019-04-13
Primary completion
2019-07-31
Completion
2019-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Diazepam Small molecule 10 mg Other
Subject Diazepam Small molecule 17.5 mg Other
Subject Diazepam Small molecule 20 mg Other

Indications